Amid the excitement about the possibility of artificial intelligence, the measured voice of Massachusetts Institute of Technology professor Daron Acemoglu, PhD, offers a sobering perspective.
The second cycle of the Medicare Drug Price Negotiation Program will offer pharma companies more time and chances to submit counteroffers during the price talks, which will take place throughout 2025.
St. Cloud, Minn.-based CentraCare has shared plans to purchase CentraCare-Monticello (Minn.) Hospital from the Monticello Hospital District Board for $2 million.
Up-and-comers in the health IT and revenue cycle spheres are taking on critical leadership positions and shaping organizational development, financial operations and care delivery.